(Q36288027)

13 August 2017

Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study (English)

1 reference

13 August 2017

1 reference

7

1 reference

13 August 2017

2

N Wentzensen

1 reference

13 August 2017

8

L A Brinton

1 reference

13 August 2017

B Trabert

1

1 reference

13 August 2017

H P Yang

3

1 reference

13 August 2017

M E Sherman

4

1 reference

13 August 2017

A Hollenbeck

5

1 reference

13 August 2017

K N Danforth

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

28 August 2012

1 reference

British Journal of Cancer

13 August 2017

1 reference

13 August 2017

107

1 reference

13 August 2017

7

1 reference

13 August 2017

1181-1187

1 reference

Hormone therapy and different ovarian cancers: a national cohort study

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Ovarian cancer and hormone replacement therapy in the Million Women Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

A prospective study of postmenopausal hormone use and ovarian cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Hormonal contraception and chemoprevention of female cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Hormone therapy and ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Menopausal hormone therapy and risk of epithelial ovarian cancer

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461172

Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study

21 October 2018

1 reference

12 December 2020

Menopausal hormone replacement therapy and risk of ovarian cancer

1 reference

12 December 2020

Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group

1 reference

12 December 2020

Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study

1 reference

12 December 2020

Menopausal hormones and risk of ovarian cancer

1 reference

12 December 2020

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort

1 reference

12 December 2020

Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen

1 reference

12 December 2020

Prevalence corrected hysterectomy rates and probabilities in Utah

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.397

1 reference

Dimensions Publication ID

13 August 2017

1014255708

0 references

Fatcat ID

release_bcwiw2rk35dypflcxijm4hois4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bcwiw2rk35dypflcxijm4hois4

24 November 2022

mapped directly with Wikidata item

1 reference

13 August 2017

PubMed publication ID

22929888

1 reference